| Variable |
OR |
95% CI |
p-value |
| CHK2 expression |
11.76 |
1.46 – 94.23 |
0.020 |
| Performance status |
77.51 |
7.83 - 767 |
0.001 |
| Synchronous metastasis |
5.34 |
1.10 – 25.88 |
0.037 |
| Tumor cell differentiation |
9.02 |
1.25 – 64.66 |
0.029 |
| Lymph node involvement |
0.24 |
0.05 – 1.01 |
0.053 |
| Gender |
0.347 |
0,.093-1.292 |
0.115 |
| Elderly (>65 years) |
0.437 |
0.126-1.518 |
0.193 |
| Histology |
1.036 |
0.214-5.016 |
0.965 |
| OPAA |
3.813 |
0.924-15.742 |
0.064 |
| Liver metastasis |
0.333 |
0.061-1.807 |
0.203 |
| Lung metastasis |
0.832 |
0.280-2.476 |
0.741 |
|
